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AbstrAct
Objectives: We sought to evaluate the utility of multidetector computed tomography (MDCT) in preoperative planning of cardiac resynchronization 
therapy (CRT) device implantation.
bAckgrOund: Variation in coronary venous anatomy can affect optimal lead placement and may warrant preimplantation visualization prior to CRT 
lead placement.
MethOds: Prospective randomized enrollment of 29 patients (17 males; mean age at implant 66.7 ± 12.8 years) was undertaken. Patients were random-
ized to preimplantation MDCT (GE® 64-detector Lightspeed, n = 16) or no MDCT. Implantation was planned based on three-dimensional coronary 
venous reconstruction as visualized in the CT group. Measurement of coronary sinus (CS) angulation, CS ostial (os) diameter, right atrial (RA) width, 
volume, and height was undertaken prior to implant. Intraoperative CS lead implantation times (introduction, cannulation, and left ventricular [LV] lead 
positioning), procedure time, fluoroscopy time, and venogram contrast volume were measured to determine if there was a difference between patients who 
underwent preimplant CT scan and those who did not.
results: CS os diameter (mean = 13.8 ± 2.9 cm) was inversely correlated with total fluoroscopy time (r = −0.57, P = .008), and total procedure time, but 
this correlation was not statistically significant (r = −0.36, P = 0.12). RA width (mean = 52.8 ± 9.9 cm) was associated with a shorter total procedure time 
(r = −0.44, P = .047) and LV lead positioning time (r = −0.33, P = .012). There were no statistically significant differences between the CT group and the 
non-CT group with respect to total intraoperative and fluoroscopy times or venogram contrast volumes. Total procedure time was longer in the CT group 
but the difference was not statistically significant (94 ± 27.2 vs. 74.7 ± 26.6; P = .065).
cOnclusiOn: Noninvasive visualization of the coronary venous anatomy before CRT implantation can be used as a guide for lead placement. While 
no significant differences were noted between the two groups with respect to intraoperative variables, CS os diameter and RA width inversely correlated 
to a shorter procedure time and LV lead positioning time, respectively. Further clinical trials regarding the utility of MDCT to visualize coronary venous 
anatomy prior to CRT implantation for procedural planning and lead placement guidance are warranted.
keywOrds: noninvasive, venous, cardiac resynchronization therapy, multidetector CT
SUPPLEMENT: Cardiovascular imaging: Current developments in research and Clinical Practice
CITATIoN: Catanzaro et al. Planning and guidance of Cardiac resynchronization therapy–lead implantation by evaluating Coronary Venous anatomy assessed by Multidetector 
Computed tomography. Clinical Medicine Insights: Cardiology 2014:8(s4) 43–50 doi: 10.4137/CMC.s18762.
RECEIVED: July 22, 2014. RESUbMITTED: october 12, 2014. ACCEPTED foR PUbLICATIoN: october 21, 2014.
ACADEMIC EDIToR: thomas e. Vanhecke, editor in Chief
TYPE: original research
fUNDING: authors disclose no funding sources.
CoMPETING INTERESTS: Authors disclose no potential conflicts of interest.
CoPYRIGhT: © the authors, publisher and licensee libertas academica limited. this is an open-access article distributed under the terms of the Creative Commons CC-By-nC 3.0 license.
CoRRESPoNDENCE: amakaryu@numc.edu
Paper subject to independent expert blind peer review by minimum of two reviewers. all editorial decisions made by independent academic editor. Upon submission manuscript was 
subject to anti-plagiarism scanning. Prior to publication all authors have given signed confirmation of agreement to article publication and compliance with all applicable ethical and 
legal requirements, including the accuracy of author and contributor information, disclosure of competing interests and funding sources, compliance with ethical requirements relating to 
human and animal study participants, and compliance with any copyright requirements of third parties. this journal is a member of the Committee on Publication ethics (CoPe).
introduction
Cardiac resynchronization therapy (CRT) has become a 
treatment option for highly symptomatic heart failure patients 
with a wide QRS complex on electrocardiography and 
depressed left ventricular (LV) systolic function.1–4 Electrical 
and mechanical cardiac dysynchrony has been shown to have 
a detrimental impact upon overall cardiac function with poor 
ventricular filling times and septal dyskinesis in addition to 
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exacerbation of preexisting valvular conditions, particularly 
mitral regurgitation.5–7
To improve CRT implant success rate, LV pacing target 
regions can be assessed before implantation. Ideally, knowl-
edge of the coronary venous anatomy should be assessed 
before noninvasive implantation, either in the outpatient clinic 
or in the hospital setting to determine whether a transvenous 
approach is feasible. Variation in coronary venous anatomy 
has been described in addition to the absence of coronary 
sinus (CS) tributaries, especially in post-myocardial infarction 
patients secondary to scarring.8 The feasibility of using multi-
detector computed tomography (MDCT) to visualize the 
coronary anatomy was previously studied, further describing 
the marked variability in venous anatomy.8
Initial experience with CRT utilized epicardial LV pacing 
through leads positioned via limited thoracotomy. This method 
of lead placement was associated with surgical risk, which led 
to the development of transvenous LV pacing techniques. With 
currently available pacemaker lead technology and appropri-
ate experience, LV pacing can be undertaken through the 
left-sided epicardial tributaries of the CS. Successful LV lead 
implantation is dependent upon the presence of preexisting 
intracardiac leads; the anatomy of the coronary veins; available 
instrumentation including guide catheters, sheaths, wires, and 
LV pacing leads; and the individual experience of the physi-
cian conducting the procedure. Furthermore, knowledge of LV 
venous anatomy may be useful beyond the actual procedure of 
LV lead implantation. Recent studies demonstrated that the 
location of the LV lead within the LV has a dramatic effect 
upon the hemodynamics of LV contraction as well as on long-
term outcomes following CRT device implantation.9
The process of gaining proper coronary access requires 
extensive knowledge of the right atrial (RA) and CS ana tomy. 
This can be individualized to each patient by imaging the coro-
nary venous system using MDCT coronary angio graphy prior to 
lead implantation. The success of CS cannulation is also implanter 
dependent, and complications have been known to arise includ-
ing coronary venous dissection, phrenic nerve stimulation, lead 
dislodgement, hematoma, and pneumothorax. Currently, there 
is a consensus that the cannulation of the CS remains the tech-
nique of choice to place the LV lead. Cannulation of the CS 
can be exceedingly difficult and time consuming using fluoros-
copy alone. The need for general anesthesia, possible intubation, 
and esophageal mani pulation further limits the utility of this 
approach.10 With preoperatively obtained MDCT, it may be 
possible to use the visualized anatomy to aid in directing CRT 
implantation. The purpose of this study was to determine the 
utility of preoperative MDCT with anatomical characterization 
of CS dimensions and tributary structure in guiding CS lead 
implantation in patients undergoing CRT implantation.
Methods
This is a prospective randomized trial targeting patients (age 
.18) with class II, III, or IV heart failure (as defined by 
the New York Heart Association [NYHA]) and an ejection 
fraction of less than 35% who were admitted to North Shore 
University Hospital and were deemed to require CRT implan-
tation as part of standard medical management. A total of 29 
patients were enrolled into the trial. Three individual implant-
ers participated in this study. Initially, patients were random-
ized to either a control group which received CRT without 
MDCT guidance or the MDCT experimental group where 
the implanters reviewed the images prior to CRT implanta-
tion. After the first 12 patients, the protocol was adjusted and 
every patient enrolled underwent a preoperative MDCT scan. 
The initial randomization was maintained, however, and the 
implanter reviewed the MDCT images of only those patients 
who were randomized into that group. Expansion of MDCT 
to all enrolled patients was implemented to further explore 
the anatomical variables. Both groups received the standard 
of care for their heart failure, which is implantation of the 
CRT. The biventricular pacing generator used was Medtronic® 
Concerto model #C154DWK for all patients. The atrial and 
ventricular leads varied and were left up to the discretion of 
the implanting electrophysiologist.
The implanter reviewed the MDCT images of the coro-
nary venous anatomy prior to CRT implantation. In order to 
minimize potential bias for trying to implant leads at a faster 
pace, the implanter was blinded to the specific variables mea-
sured during the procedure. A health-care provider was pres-
ent in the operating room during the procedure to perform 
data collection intraoperatively.
informed consent and follow-up. Following approval by 
the institutional review board of the North Shore LIJ Health 
System, the study began with the recruitment of eligible 
patients. The patients who were randomized to receive MDCT 
were consented and then underwent CRT. Patients enrolled in 
the trial were followed up within 48 hours and received routine 
phlebotomy to monitor their serum creatinine levels following 
the CT scan. This research was conducted in accordance with 
the principles of the Declaration of Helsinki.
Participation criteria. Inclusion criteria stated that 
all patients must be $18 years of age with Stage II, III, or 
IV heart failure who have a creatinine #1.6 mg/dL. These 
patients were already admitted to North Shore University 
Hospital and were scheduled to undergo CRT for their heart 
failure as standard of care. Also, patients must not have 
undergone CRT implantation in the past. Patients with atrial 
fibrillation were not excluded. Exclusion criteria pertained 
to any patient less than 18 years of age or who did not meet 
NYHA HF class II, III, or IV criteria, was not eligible for 
CRT implantation based upon current guidelines, and who 
had a creatinine level greater than 1.6 mg/dL.
variables analyzed and endpoints. The primary endpoint 
was total procedure time, which was defined as time from ini-
tial incision to wound closure. Additional para meters analyzed 
intraoperatively and compared with the control group (where 
the implanter did not review the MDCT) included CS access 
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to CS cannulation time, CS cannulation to LV introduction 
time, LV introduction to positioning, LV lead time (measured 
from initial CS access to successful LV lead positioning), total 
fluoroscopy time, and volume of dye used during venogram.
Mdct anatomical measurements. All patients were 
scanned with an MDCT scanner (GE® LightSpeed VCT, GE 
Healthcare Amersham Health, Princeton, NJ, USA) equipped 
with 64-MDCT technology. Scan parameters were as follows: 
number of slices per rotation, 64; individual detector slice width, 
0.625 mm; and 12.5-cm spatial coverage in 5 seconds at a gantry 
rotation speed of 330 ms. After the patient was advanced into 
the scanner bore, a 20-mL test bolus of contrast was adminis-
tered. Images were then obtained over the CS body to time the 
arrival of contrast material to the coronary veins. The scan was 
timed when a threshold of approximately 100 Hounsfield units 
was reached in the CS body. Patients were asked to breathe 
deeply and then hold their breath. After bolus administration of 
70 mL of nonionic iodinated contrast material (Omnipaque 
[iohexol]; GE Healthcare, Amersham Health) at a flow rate of 
5 ml/s, image acquisition was performed. The scan time was 
approximately 10 seconds (one breath-hold).
Image acquisition was performed at 10% increments 
through the R-R cardiac cycle interval. After retrospectively 
gated image acquisition to allow for the full cardiac cycle 
phase acquisition, images were transferred to a GE® AW 
workstation where they were reconstructed with the appropri-
ate electrocardiogram (ECG) gating phase for adequate image 
and structure visualization and interpreted by an experienced 
reader. Specific attention was focused on analysis of the ana-
tomic characterization of the coronary venous system.
The tributaries of the cardiac venous system were also 
identified on axial and volume-rendered reconstructions and 
a 3-dimensional (3D) reconstruction of the venous system 
was created. The presence of the following cardiac veins was 
evaluated: CS, great cardiac vein, anterior interventricular 
vein, middle cardiac vein (posterior interventricular), lateral 
cardiac vein (marginal vein), and posterolateral cardiac vein. 
Quantitative parameters were also assessed. The ostium of the 
CS was defined as the site where the CS makes an angle with 
the RA. Multiplanar reformatting of axial images was used 
to determine the CS ostial (os) diameter and CS angulation. 
Further, RA height and width were quantified.
surgical procedure. Standard surgical technique was 
employed. The right ventricular lead was advanced under 
fluoroscopic guidance to the right ventricular apex and 
secured by passive fixture. The CS was visualized using GE® 
Iohexol contrast dye and the CS cannulated using fluoro-
scopic guidance to allow lead entry and positioning into the 
posterolateral position to pace the LV without diaphragmatic 
stimulation. Two-dimensional fluoroscopic visualization of 
CS tributaries was obtained during LV lead implantation. 
A CS occlusion balloon was inflated and contrast injected ret-
rograde to blood flow in order to opacify the coronary venous 
system. The RA lead was then advanced under fluoroscopic 
guidance to the RA and secured by active fixture. Accept-
able pacing and sensing parameters were obtained. The pulse 
generator was attached to the leads, and the set screws were 
tightened and verified. The defibrillator was placed into the 
pocket. Defibrillation threshold testing was then performed. 
Finally, postprocedure chest radiograph was ordered and 
checked for lead placement.
statistical methods. The primary endpoint variable of 
the study was the total procedure time. The Mann–Whitney 
test was used to compare the various time parameters between 
the two treatment arms. Correlations (Spearman) were calcu-
lated to determine the strength of correlations among various 
CT scan parameters (RA volume, RA width, RA height, CS 
angulation, and CS os diameter) and parameters of interest 
(time to sinus lead implantation, time to CS cannulation, fluo-
roscopy time, volume contrast, total procedure time, etc.)
results
There were a total of 29 patients who completed the study. 
Baseline patient characteristics included age, race, American 
Heart Association Heart Failure Class (I–IV), and medica-
tion regimens (Table 1). Of the 29 patients overall, the mean 
age at time of enrollment was 66.7 ± 12.8 years (range 39–87 
years). In the patient cohort, 12.5% (2/29), 81.25% (13/16), and 
6.25% (1/16) patients were classified as heart failure classes II, 
III, and IV, respectively.
intraoperative parameters. There were no statistically 
significant differences between the MDCT group and the 
non-MDCT group with respect to intraoperative lead implan-
tation times, venogram contrast volume, and fluoroscopy 
times. Table 2 lists the individual steps and times recorded 
from initial CS access time through final LV lead positioning, 
fluoroscopy time, and venogram contrast volume.
coronary venous anatomical measurements. Among 
all CT scans, CS os diameter (mean = 13.4 ± 2.9 cm) was 
inversely correlated with total procedure time, though 
this correlation was not statistically significant (r = −0.35, 
P = .1234). CS os diameter was also inversely correlated with 
the total fluoroscopy time (r = −0.57, P = .0084). Figure 1 
demonstrates the scatter plot and the trend line for both cor-
relations. RA width (52.8 ± 10.1 mm) was inversely correlated 
with total procedure time (r = 0.45, P = .0469) and LV lead 
positioning time (r = −0.33, P = .012). Figure 2 demonstrates 
the scatter plot of total procedure time versus RA diameter 
with a trend line.
venous anatomy. Eight cardiac venograms were deemed 
to be of acceptable quality (with sufficiently distal contrast 
penetration) and were compared to 3D reconstructions of the 
coronary venous system (Fig. 3). Out of four anterior, seven 
lateral, five middle, and six posterior veins identified on fluo-
roscopy, the MDCT scans identified 4/4 anterior veins (100%), 
4/7 lateral veins (57%), 3/5 middle veins (60%), and 4/6 pos-
terior veins (66.7%). For the instances where the vessels were 
not visualized on fluoroscopy (four anterior, one lateral, two 
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middle, and two posterior veins), the CT result was concurrent 
in 1/4 (25%), 0/1, (0%), 1/2 (50%) and 2/2 (100%) instances.
discussion
When CRT was introduced as a potential therapeutic option 
for patients with medical therapy–refractory heart failure, 
operators depended upon epicardial LV pacing conducted 
via leads that were placed via a limited thoracotomy, a pro-
cedure which carried an obvious surgical risk.8 Since the 
introduction of CRT, new techniques to facilitate implan-
tation have been developed so as to justify the risk–benefit 
ratio associated with the procedure. The utilization of trans-
venous lead placement has resulted in significantly reduced 
morbidity and mortality, facilitating a potentially challeng-
ing procedure.
Despite the technical utility of utilizing the transvenous 
approach, variations in vascular anatomy have the potential to 
render even this less invasive procedure more difficult, result-
ing in increased operative times, exposure to fluoroscopy, con-
trast dosages, and errors in lead placement. As a result, precise 
knowledge of coronary vascular anatomy prior to implantation 
has the potential to decrease the morbidity associated with 
unexpected vascular variations. The expansion of available 
noninvasive means to accurately assess the cardiac arterial and 
venous system, particularly via coronary CT angiography and 
magnetic resonance angiography, may alter the way in which 
we approach CRT. Prior to the modern era of noninvasive 
cardiac visualization, coronary veins could only be visualized 
via retrograde venography, an invasive procedure that carries 
with it the risks associated with any type of invasive angio-
graphy including infection, vascular disturbance, and contrast-
induced nephropathy, as well as exposure to fluoroscopy.11–13 
Over the past five years, however, numerous studies indicating 
good results with noninvasive assessment of the coronary 
venous system in particular have been published.
The use of MDCT angiography to assess coronary arter-
ies has been studied extensively. The utility of this technology 
in the evaluation of the venous system, however, is less proven. 
In 2000, Schaffler et al demonstrated adequate delineation of 
the venous system (particularly the CS and its tributaries) and 
its spatial relation to other cardiac structures using ECG-
triggered electron beam CT.14 Mao et al examined the use of 
electron beam computed tomography to visualize the venous 
system, relationships to coronary arteries, and the presence 
of unexpected venous anomalies.15 More recently, several 
other studies examining the use of 16- and later 64-MDCT 
have demonstrated success in adequately mapping venous 
structures. Despite concerns over inadequate venous opaci-
fication given that the MDCT studies were geared toward 
visualization of the arterial system, venous anatomy could be 
adequately delineated in the vast majority of patients. Infor-
mation regarding vessel lengths, diameters, course, and rela-
tion to other anatomic structures was readily available from 
analysis of the CT images.16,17
The clinical implications of precise knowledge of the 
venous anatomy prior to implantation can be very significant 
for many aspects of electrophysiology. While the information 
obtained from MDCT can certainly be useful for procedures 
such as radiofrequency ablation and myoblast transplanta-
tion performed via catheter-based procedures, the signifi-
cant technical difficulties that are often encountered during 
CRT implantation make application of noninvasive imaging 
to this procedure even more significant. There is a significant 
potential for cardiac venous anatomical variation particularly 
with reference to the task of localizing lateral and posterior 
venous branches of the venous system.18 In 2005, Jongbloed 
et al used MDCT to map variations in the cardiac venous 
system, noting significant interindividual differences in the 
origin and continuity of the major venous tributaries as well as 
Table 2. intraoperative parameters.
INTRAoPERATIVE  
PARAMETERS
64 CT  
(n=16)
No 64 CT  
(n=13)
P-VALUE
initial Cs access time  
to Cs cannulation time
10.81 ± 16.95 5.23 ± 7.34 0.15
Cs cannulation time to  
lV introduction 
10.53 ± 16.64 5.85 ± 5.89 0.87
lV introduction to  
lV lead positioning
9.07 ± 9.22 9.46 ± 8.24 0.81
lV lead time (Cs access  
to successful lV lead 
positioning) 
31.69 ± 22.07 20.54 ± 14.10 0.29
total Procedure time 94.00 ± 27.16 74.69 ± 26.60 0.17
Fluoroscopy time 15.34 ± 12.45 13.67 ± 8.33 0.38
Venogram Contrast  
Volume 
44.07 ± 99.24 14.00 ± 9.88 0.17
Table 1. Baseline characteristics.
bASELINE  
ChARACTERISTICS
CT GRoUP  
(n=16) 
No CT GRoUP 
(n=13) 
age ,65 yrs 7 2
age $65 yrs 9 11 
nyha heat Failure Class
heart Failure Class ii 1 1
heart Failure Class iii 14 12
heart Failure Class iV 1 0 
race
Caucasian 12 13
african american 4 0
Medications
ace inhibitors 8 7 
Beta-Blockers 13 8 
asa 9 6 
anti-arrhythmics 3 3 
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figure 1. Correlation between CS os diameter (red line across the sagittal CT section) and total procedure and total fluoroscopy times. Both times display 
significant inverse correlation with CS os diameter.
the number of vessels, particularly posterolateral tributaries, 
available for cannulation of the CS.8 As a result, knowledge 
of the presence of unexpected variations in anatomy prior to 
CRT implantation can be a boon to the operator.
Anatomical variation has led to a unique classification of 
the venous system. Singh et al proposed using a segmental 
approach to classifying the CS branches and tributaries by 
the segment of myocardium that a particular vein or venous 
tributary overlies utilizing their original location rather than 
anatomical designations.19 Studies have also concentrated on 
targeting the anatomic origin of the venous system and apply-
ing noninvasive visualization of the venous anatomy prior to 
Catanzaro et al
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radiofrequency ablation. Tada et al enrolled 70 patients (65 
had paroxysmal atrial fibrillation and atrial tachycardia) who 
underwent MDCT to determine the morphology and size of 
the left atrium and pulmonary veins prior to ablation. Visu-
alization was possible in 91% of the patients with specific 
visualization of the lateral aspect of the LV with at least one 
vein being invariably detected and two veins visualized in 
36% of patients and more than two veins in 45% of enrolled 
patients.20
The feasibility of noninvasive evaluation of the coronary 
veins has been confirmed in populations of patients with and 
without coronary artery disease as well as prior infarction. Van 
de Veire et al studied venous anatomy with MDCT in 100 
patients comprising three groups: control patients, patients 
with coronary artery disease, and patients with a history of 
prior myocardial infarction. The CS, middle cardiac vein, and 
posterior vein of the LV were identified in all subjects. The left 
marginal vein was observed significantly less in patients with 
a previous history of myocardial infarction.21 Absence of LV 
tributaries in patients with a history of myocardial infarction 
may lead to more difficult lead positioning techniques which 
may also impart longer fluoroscopy exposure and longer pro-
cedure times. Drastic alterations in venous anatomy may pre-
clude transvenous placement of LV lead altogether, leading 
to a surgical implantation. Clinical implications of preopera-
tive visualization of the coronary venous system specifically 
the lateral aspect of the LV can contribute to successful lead 
implantation for CRT.
Our study demonstrates the capacity of MDCT to 
delineate large venous structures as well to characterize the 
environment through which the LV lead must be advanced to 
achieve optimal LV pacing. By utilizing 3D reconstruction, 
CS os diameter, angulation, RA, height, and width could 
be assessed with great accuracy thereby providing a wealth 
of information prior to introduction of the leads required for 
CRT. Furthermore, we showed that MDCT can be used to 
reconstruct coronary venous structures with accurate fidelity 
compared to intracoronary venograms. The ability to predict 
availability of appropriate target vessels is an additional utility 
of MDCT scanning prior to CRT implantation.
The ability of MDCT to provide information regard-
ing the venous anatomy becomes even more important when 
attempting more technically challenging procedures such as 
CRT. The implantation of a biventricular pacemaker usually 
requires stimulation of the LV, which is currently most often 
achieved via the transvenous approach, usually through a trib-
utary of the CS. The need for placement of a LV lead neces-
sitates knowledge of the posterolateral cardiac venous anatomy 
to facilitate access to the often small, tortuous tributaries of 
the CS.15–17 In addition, variations in the angle and diameter 
of the great cardiac vein could make cannulation of a LV vein 
more challenging, thus increasing operative times, exposure 
to fluoroscopy and the potential for suboptimal lead place-
ment. In addition to facilitating the actual procedure, visual 
knowledge of the venous anatomy prior to the procedure may 
prepare the operator for the degree of difficulty of the proce-
dure and even guide selection of equipment. As a result, there 
is a significant potential benefit for utilizing coronary CT 
angiography prior to attempting BVP implantation, and as the 
spatial and temporal resolution available for CTA increases, 
so will the amount of information that can be garnered from 
these studies.
Our data showed that there was no statistically signifi-
cant difference between the MDCT group and non-MDCT 
group with respect to intraoperative times, fluoroscopy time, 
or venogram contrast volume. These findings are likely due 
to the small sample size of the study. Comparison of the two 
groups of patients showed that although not significant, the 
Coronary sinus
Right atrium
Ant interventricular vein
Lateral marginal vein
Middle cardiac vein
figure 3. 3d reconstruction of the coronary venous system.
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majority of the intraoperative variables measured, including 
initial CS access time, time of CS cannulation, LV introduc-
tion time, and time of final LV lead positioning took longer to 
complete in the MDCT group. Difficulties in lead advance-
ment intuitively would likely cause a low lead implantation 
success rate, longer times of fluoroscopy use and larger quanti-
ties of dye, as was the case when comparing the two groups of 
patients. The anatomy through which the LV lead is advanced 
consists of the subclavian vein, the superior vena cava, the RA, 
the CS os, and the course of the CS as well as its tributaries. 
The anatomic dimensions of these structures can vary from 
patient to patient and can drastically affect the CRT implan-
tation procedure, as demonstrated by the broad range of intra-
operative variable measurements. The intrinsic environment of 
the venous system itself specifically the Valve if Vieussens and 
Thebesian valves may pose a mechanical or obstructive threat 
toward a successful, shorter lead implantation. Another expla-
nation for the increased times seen in the MDCT group may 
relate to the inherent learning curve by implanters in using 
the CT images to guide lead placement compared to use of 
more familiar CS venograms for guidance. This highlights an 
important point that familiarity, and a certain experience is 
required in interpreting these MDCT images for them to be 
used in a beneficial manner.
We showed that greater the CS os diameter and RA 
width, shorter is the CS lead implantation time. The CS os 
diameter and the course of the CS play an important role in 
determining the success of lead advancement toward the opti-
mal posterolateral position of the LV. It may also be possible to 
use MDCT to exclude patients from transvenous lead implan-
tation. Knowledge of a small CS os preoperatively may warrant 
epicardial lead placement to pace the LV. Perhaps there lies a 
critical diameter of the CS os, which would direct implanters 
toward an epicardial approach. Preoperative knowledge of the 
CS os diameter and RA dimensions may allow implanters to 
stratify patients into a group that would be more technically 
difficult or less suited for a successful, shorter, and safer trans-
venous approach to CRT implantation. Figure 3 shows a full 
3D reconstruction of the CS, its course, and major tributaries. 
Our data indicate that this 3D reconstruction may be used 
with high certainty to predict the presence of appropriate trib-
utaries for LV lead placement. Smaller caliber vessels that may 
have been noted on fluoroscopy may not have been visualized, 
but these caliber vessels are too small for lead advancement 
and therefore are of no major clinical significance. Use of this 
“roadmap” preimplantation may guide the implanter toward 
the optimal posterolateral lead implantation site, thereby 
achieving cardiac resynchronization.
The utility of MDCT in CRT is likely to expand beyond 
facilitating the actual procedure and to affecting the long-
term outcomes of CRT therapy as our experience with resyn-
chronization grows. At present, implantation of the LV lead 
is targeted to the lateral/posterior wall of the LV. The reason-
ing behind this approach is that positioning the lead as far 
away from septum and to the latest depolarizing section of the 
ventricle should have the greatest impact in LV dyssynchrony. 
However, recent work by Merchant et al indicates that simply 
positioning the LV lead in the lateral/posterolateral position 
of the LV lead is not always sufficient and longitudinal out-
comes depend on the leads’ position along the long axis of 
the ventricle as well.22 Specifically, patients undergoing CRT 
were divided into two groups based on the final location of 
the LV lead; apical or basal/midventricular. After 15 months 
of follow-up, the group with the apical lead demonstrated a 
clinical severity–adjusted HR of event-free survival of 2.3 
compared to the basal/midventricular group. NYHA and LV 
remodeling were also adversely affected. Derval et al recently 
demonstrated that hemodynamic and echocardiographic 
changes induced by resynchronization vary dramatically in 
each patient based on the position of the LV lead, that position 
not being limited to the posterior/lateral sites of the ventricle 
traditionally utilized.23 As the role of the pacing site location 
becomes more important, the individual venous anatomy of 
each patient will become crucial in planning the CRT proce-
dure and affecting long-term outcomes.
conclusion
Noninvasive visualization of the coronary venous anatomy 
before CRT implantation can be used as a guide for lead 
placement. Lead placement and choice of approach (trans-
venous vs. epicardial) can be directly and indirectly affected 
by variations in anatomy and limitations in anatomical 
dimensions through which the lead is advanced. Our study 
shows that intracardiac venous anatomy, in particular CS os 
diameter and RA width, do play a role in predicting optimal 
lead positioning by visualizing CS anatomy and course. Fur-
ther analysis of the use of MDCT as a guide for CRT lead 
implantation is warranted.
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